Using GLP-1 receptor agonist medications like Semaglutide, Tirzepatide, Mounjaro, Zepbound, Wegovy, and Ozempic, the program ensures that treatments align with your unique health profile and goals
Bupropion: An antidepressant medication that can impact the brain's reward system and appetite
On average, GLP-1s can lead to 15% or more body weight reduction, and for those who have lived with obesity for years, their lives will change dramatically. Tran says using GLP-1s can lead to less spending on food, with users eating smaller portions, cutting unnecessary snacking, finding fast food less appealing, and experiencing reduced cravings for high-sugar foods
All medications are FDA approved, ensuring safety and efficacy